ONCSQ (OncoSec Medical) Float Percentage Of Total Shares Outstanding: 87.20% (As of Jun. 28, 2026)


What is OncoSec Medical Float Percentage Of Total Shares Outstanding?

OncoSec Medical ONCSQ -99.00% Float Percentage Of Total Shares Outstanding is 87.20% as of Jun. 28, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OncoSec Medical's float shares is 5.20 Mil. OncoSec Medical's total shares outstanding is 5.96 Mil. OncoSec Medical's float percentage of total shares outstanding is 87.20%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OncoSec Medical's Insider Ownership is 44.34%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OncoSec Medical's Institutional Ownership is 0.00%.

OncoSec Medical Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

OncoSec Medical's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=5.20/5.96
=87.20%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 87.20% mean?
OncoSec Medical (ONCSQ) has a Float Percentage Of Total Shares Outstanding of 87.20% as of Jun. 28, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Float Percentage Of Total Shares Outstanding too high?
OncoSec Medical's current Float Percentage Of Total Shares Outstanding is 87.20%.
How does OncoSec Medical's Float Percentage Of Total Shares Outstanding compare to NOVNQ and USRM?
OncoSec Medical's Float Percentage Of Total Shares Outstanding of 87.20% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Float Percentage Of Total Shares Outstanding is 87.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Float Percentage Of Total Shares Outstanding of 87.20%. The current Float Percentage Of Total Shares Outstanding is 87.20%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Float Percentage Of Total Shares Outstanding is 87.20% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.